SGX Compounders: 10 Singapore Stocks for the Long Run

Singapore stocks have a reputation for one thing: dividends.

For years, investors have looked to the local market for reliable banks, property trusts and income-generating businesses, while turning to the US for growth.

But Singapore has its own collection of companies capable of building value over time.

Some dominate established industries. Others are expanding into new markets, benefiting from structural trends or reinvesting earnings to grow their businesses.

The common thread is compounding: the ability to grow earnings and shareholder value over many years.

Here are ten Singapore-listed companies worth keeping on a long-term watchlist, grouped by how they might create value.

1. DBS Group (D05) — The Banking Powerhouse

Singapore’s largest bank has built a leading regional franchise across consumer banking, corporate lending and wealth management.

Its digital capabilities, deposit base and wealth-management business provide competitive advantages, while dividends and capital returns are important components of shareholder value.

In the first half of 2026, net profit rose 5% to a record S$6.01 billion, with a return on equity of 17.5%.

2. Singapore Exchange (S68) — The Market’s Toll Collector

SGX is more than Singapore’s stock exchange. It operates securities, derivatives, clearing and market-data businesses.

In FY2026, net revenue reached S$1.48 billion, up 13.9%, supported by its diversified market infrastructure operations.

3. Sheng Siong (OV8) — The Quiet Compounder

A supermarket may not sound like an exciting investment. But everyday essentials create recurring demand, and Sheng Siong has demonstrated how store expansion and operational discipline can grow a business.

In the first half of 2026, revenue rose 11.9% to S$855.4 million, while net profit increased 11.9% to S$81 million.

4. OCBC (O39) — The Banking and Wealth Franchise

OCBC combines traditional banking with wealth management, insurance and regional exposure.

Its diversified financial-services model offers opportunities to earn income across different parts of a customer’s financial life.

In the first half of 2026, net profit rose 13% to S$4.19 billion. Wealth-management income reached a record S$3.29 billion, or 41% of total income.

5. ST Engineering (S63) — The Global Engineering Business

ST Engineering operates across aerospace, defence, public security and technology.

Its appeal lies partly in the visibility provided by long-term contracts and exposure to industries where customers cannot easily replace established suppliers.

In the first half of 2026, revenue rose 11% to S$6.57 billion, while net profit increased 27% to S$512 million. Its order book reached S$35.7 billion.

6. iFAST Corporation (AIY) — The Wealth-Tech Platform

iFAST operates investment and wealth-management platforms serving financial advisers, institutions and individual investors.

As more savings move into investment products, scalable financial platforms could benefit from growing assets and recurring fees.

In FY2025, iFAST generated S$339.7 million in net revenue, with net profit attributable to shareholders of S$100.0 million, up 50%. In the first half of 2026, net profit rose about 41% to S$57.9 million, and assets under administration reached a record S$36.1 billion.

7. Singtel (Z74) — More Than a Telecom Operator

Singtel’s investment case increasingly extends beyond Singapore’s mobile market.

Its regional telecommunications investments, enterprise technology business and digital infrastructure operations give it exposure to growth across Asia.

For FY2026, underlying net profit rose 12% to S$2.77 billion. The company has also been recycling capital from selected investments.

8. Venture Corporation (V03) — The Advanced Manufacturing Specialist

Venture manufactures sophisticated products and provides technology solutions for customers across industrial, medical and other technology markets.

Its investment appeal comes from engineering capabilities, long-term customer relationships and exposure to increasingly complex products.

In the first half of 2026, revenue rose 7.4% to approximately S$1.35 billion, while net profit increased 5.6% to S$119.3 million.

9. Raffles Medical Group (BSL) — The Healthcare Expansion Bet

Raffles Medical operates clinics, hospitals and healthcare services, with a presence in Singapore and China.

Healthcare demand has long-term demographic support, but expanding hospital operations can require substantial investment before returns become visible.

In the first half of 2026, revenue declined 6.7% to S$353.2 million, while attributable profit fell 9.6% to S$29 million.

10. SATS (S58) — The Global Aviation Infrastructure Play

SATS provides ground-handling, food solutions and air-cargo services.

Its expanded international footprint gives it exposure to global aviation and logistics, but also introduces significant operational complexity.

In FY2026, revenue rose 9.0% to S$6.35 billion, while profit attributable to shareholders increased 17.0% to S$285.2 million.

There is another distinction worth making: dividends are only part of the equation.

A company that pays a generous dividend but struggles to grow earnings may create less wealth over a decade than one that reinvests successfully and compounds its profits.

For Singapore investors, the real test is not simply whether a stock is familiar, defensive or pays a reliable dividend.

It’s whether the business can grow earnings and cash flow, allocate capital intelligently and continue creating value—without investors overpaying for that future.

The best compounders don’t necessarily make the most headlines. They make the most of time.